In scenarios where you might have to have use of a medically-important drug for a significant or daily life-threatening issue in which there is not any market place authorized drug out there in copyright and for which alternate regular therapies have unsuccessful or are unsuitable, Overall health copyright's Particular Accessibility Programme (SAP)